Business
Clinical-trial research company Clario announces new hire, and AI-enabled surgical care organization Apella and data company Brillio announce additions to their board of directors.
The companies' joint offering, ThinkSono Guidance, attained Class IIb CE mark approval in March with upcoming plans for FDA approval.
HIMSS24
Richard Staynings, chief security strategist at Cylera, talks about a study exposing how AI in smart medical devices could be vulnerable to cyberattack, as well as how microsegmentation and firewall controls can help prevent such attacks.
Stock exchange rules give Amwell six months to comply with its minimum price requirement of $1 per share or be delisted. Amwell last traded above $1 in March.
Psychiatrist, neuropsychiatrist and founder of Stanford University's Virtual Reality and Immersive Technology Lab, Dr. Kim Bullock, discusses XR use in psychotherapy, Apple Vision Pro and ensuring validity in mental healthcare offerings.
The company's chief financial officer, Mala Murthy, will step in as acting CEO.
HIMSS24
Matthew Ko, cofounder, president and COO of DeepScribe, describes how the company addressed clinicians' concerns by building a "customization studio" that allows editing of AI-generated visit notes to reflect clinicians' natural writing style.
The partnership seeks to close the recovery gap between hospital and at-home care by offering in-home follow-up appointments.
The partnership will expand cardiovascular care to areas without specialized infrastructure like CT imaging.
Dr. Brian Hasselfeld, senior medical director of digital health and innovation at Johns Hopkins Medicine, talks about using AI-powered ambient scribe technology to address physicians' documentation burden from the explosion of EMR content.